Development of Venous Thromboembolism After COVID-19 mRNA-1273 Vaccine Inoculation

被引：4
|
作者：
Mahgoub, Abdullahi E. [1 ,2 ]
Awuah, Dominic [1 ,2 ]
Hussain, MurtazaShabbir [1 ,2 ]
Deliwala, Smit [1 ,2 ]
Bachuwa, Ghassan [1 ,2 ]
Younas, Mariam [2 ,3 ]
机构：
[1] Hurley Med Ctr, Internal Med, Flint, MI 48503 USA
[2] Michigan State Univ, Coll Human Med, Lansing, MI 48824 USA
[3] Hurley Med Ctr, Infect Dis, Flint, MI USA
来源：
CUREUS JOURNAL OF MEDICAL SCIENCE | 2022年 / 14卷 / 02期
关键词：
covid vaccines; vaccine induced thrombosis; venous thromboembolism; mrna-1273; vaccine; covid-19; THROMBOSIS;
D O I：
10.7759/cureus.22179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 79-year-old man suddenly developed right lower extremity (RLE) pain and swelling a few days after receiving his 1st dose of the mRNA-1273 COVID-19 vaccine. Despite this, he proceeded to receive the 2nd dose of his mRNA-1273 COVID-19 vaccine. Investigations confirmed extensive acute deep venous thrombosis and a concurrent acute pulmonary embolism. Therapeutic anticoagulation was initiated and he was eventually discharged home on supplemental oxygen. The overall benefits of the vaccine in curbing severe disease overwhelmingly outweigh the handful of cases of reported adverse events. To our knowledge, this is one of the first few cases of provoked venous thrombosis after receiving the mRNA-1273 COVID-19 vaccine during the pharmacovigilance period.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine
    Ntelis, Spyridon
    Champ, Kathryn
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2022, 12 (04):
  • [2] Severe Diabetic Ketoacidosis After the Second Dose of mRNA-1273 COVID-19 Vaccine
    Zilbermint, Mihail
    Demidowich, Andrew P.
    JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 2022, 16 (01): : 248 - 249
  • [3] Myocarditis following COVID-19 mRNA (mRNA-1273) vaccination
    Chellapandian, Suresh Babu
    Turkmen, Suha
    Salim, Imtiaz
    Chinnakaruppan, Shanmugavel
    Mohammad, Jassim
    CLINICAL CASE REPORTS, 2022, 10 (04):
  • [4] Status epilepticus as a complication after COVID-19 mRNA-1273 vaccine: A case report
    Sin, Robin
    Struncova, Denisa
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (24) : 7218 - 7223
  • [5] Analysis of the adverse events following the mRNA-1273 COVID-19 vaccine
    Shabu, Angel
    Nishtala, Prasad S.
    EXPERT REVIEW OF VACCINES, 2023, 22 (01) : 801 - 812
  • [6] Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
    van Leeuwen, Leanne P. M.
    GeurtsvanKessel, Corine H.
    Ellerbroek, Pauline M.
    de Bree, Godelieve J.
    Potjewijd, Judith
    Rutgers, Abraham
    Jolink, Hetty
    van de Veerdonk, Frank
    van Gorp, Eric C. M.
    de Wilt, Faye
    Bogers, Susanne
    Gommers, Lennert
    Geers, Daryl
    Bruns, Anke H. W.
    Leavis, Helen L.
    van Haga, Jelle W.
    Lemkes, Bregtje A.
    van der Veen, Annelou
    de Kruijf-Bazen, S. F. J.
    van Paassen, Pieter
    de Leeuw, Karina
    van de Ven, Annick A. J. M.
    Verbeek-Menken, Petra H.
    van Wengen, Annelies
    Arend, Sandra M.
    Ruten-Budde, Anja J.
    van der Ent, Marianne W.
    van Hagen, P. Martin
    Sanders, Rogier W.
    Grobben, Marloes
    van der Straten, Karlijn
    Burger, Judith A.
    Poniman, Meliawati
    Nierkens, Stefan
    van Gils, Marit J.
    de Vries, Rory D.
    Dalm, Virgil A. S. H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) : 1949 - 1957
  • [7] Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
    Puranik, Arjun
    Lenehan, Patrick J.
    O'Horo, John C.
    Pawlowski, Colin
    Virk, Abinash
    Swift, Melanie D.
    Kremers, Walter
    Venkatakrishnan, A. J.
    Challener, Doug W.
    Breeher, Laura
    Gordon, Joel E.
    Geyer, Holly L.
    Speicher, Leigh Lewis
    Soundararajan, Venky
    Badley, Andrew D.
    PNAS NEXUS, 2022, 1 (02):
  • [8] Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine
    Tangsathapornpong, Auchara
    Nanthapisal, Sira
    Pontan, Kanassanan
    Bunjoungmanee, Pornumpa
    Neamkul, Yamonbhorn
    Boonyarangkul, Arthit
    Wanpen, Supattra
    Fukpho, Waraphon
    Jitpokasem, Sumana
    Tharabenjasin, Phuntila
    Jaru-Ampornpan, Peera
    VACCINES, 2023, 11 (03)
  • [9] Delayed Skin Reactions to COVID-19 mRNA-1273 Vaccine: Case Report and Literature Review
    Wang, Ruei-Lin
    Chiang, Wen-Fang
    Chiu, Chih-Chiun
    Wu, Kuo-An
    Lin, Chia-Yi
    Kao, Yung-Hsi
    Chuu, Chih-Pin
    Chan, Jenq-Shyong
    Hsiao, Po-Jen
    VACCINES, 2022, 10 (09)
  • [10] Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination
    Shin, Sun Hye
    Hong, Jun Ki
    Hong, Soon Auck
    Li, Kapsok
    Yoo, Kwang Ho
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 114 : 88 - 89
12345